Accuracy of screening mammography varies by week of menstrual cycle

Radiology

Volumn 258, Issue 2, 2011, Pages 372-379

  Miglioretti, Diana L ^a,b   Walker, Rod ^a   Weaver, Donald L ^c   Buist, Diana S M ^a,b,d   Taplin, Stephen H ^e   Carney, Patricia A ^f   Rosenberg, Robert D ^g   Dignan, Mark B ^h   Zhang, Zhuo ^b   White, Emily ^b,d  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLICULAR PHASE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUTEAL PHASE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; WOMEN'S HEALTH;

ADULT; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MENSTRUAL CYCLE; MIDDLE AGED; POPULATION SURVEILLANCE; PREMENOPAUSE; PROSPECTIVE STUDIES; REGISTRIES; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 79952318100     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100974     Document Type: Article

References (46)

1. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151(10):727- 737, W237-W242.
2. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(5 part 1):347-360.
3. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151(10):738-747.
4. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273(2):149-154.
5. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138(3):168-175.
6. Peer PG, Verbeek AL, Straatman H, Hendriks JH, Holland R. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 1996;38(2):153-160.
7. Yankaskas BC, Haneuse S, Kapp JM, et al. Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst 2010;102(10):692-701.
8. Ernster VL. Mammography screening for women aged 40 through 49: a guidelines saga and a clarion call for informed decision making. Am J Public Health 1997;87(7):1103-1106.
9. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151(10):716-726, W-236. [Published correction appears in Ann Intern Med 2010;152(3):199-200.]
10. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15(1):196-208.
11. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000;11(10):955-963.
12. Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 2004;90(2):393-396.
13. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276(1):33-38.
14. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992;84(10):781-785.
15. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992;184(3):613-617.
16. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of intervaland screen-detected cancers. J Natl Cancer Inst 2000;92(13):1081-1087.
17. Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst 2004;96(19):1432-1440.
18. White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998;90(12):906-910.
19. Ursin G, Parisky YR, Pike MC, Spicer DV. Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2001;10(2):141-142.
20. Morrow M, Chatterton RT Jr, Rademaker AW, et al. A prospective study of variability in mammographic density during the menstrual cycle. Breast Cancer Res Treat 2010;121(3):565-574.
21. Buist DS, Aiello EJ, Miglioretti DL, White E. Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2006;15(11):2303-2306.
22. Baines CJ, Vidmar M, McKeown-Eyssen G, Tibshirani R. Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study. Cancer 1997;80(4):720-724.
23. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 1997;169(4):1001-1008.
24. National Cancer Institute. Breast Cancer Surveillance Consortium Standardized Questionnaires. National Cancer Institute Web site. http://breastscreening.cancer.gov/data/elements.html#questionnaires. Accessed May 13, 2010.
25. National Cancer Institute. Breast Cancer Surveillance C. BCSC Glossary of Terms. National Cancer Institute Web site. http://breastscreening.cancer.gov/ data/bcsc-data-definitions.pdf. Accessed May 13, 2010.
26. American College of Radiology. American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). 4th ed. Reston, Va: American College of Radiology, 2003.
27. Yankaskas BC, Taplin SH, Ichikawa L, et al. Association between mammography timing and measures of screening performance in the United States. Radiology 2005;234(2):363-373.
28. Hovhannisyan G, Chow L, Schlosser A, Yaffe MJ, Boyd NF, Martin LJ. Differences in measured mammographic density in the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2009;18(7):1993-1999.
29. Kerlikowske K, Grady D, Barclay J, et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 1998;90(23):1801-1809.
30. Berg WA, Campassi C, Langenberg P, Sexton MJ. Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. AJR Am J Roentgenol 2000;174(6):1769-1777.
31. Ooms EA, Zonderland HM, Eijkemans MJ, et al. Mammography: interobserver variability in breast density assessment. Breast 2007;16(6):568-576.
32. Ciatto S, Houssami N, Apruzzese A, et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast 2005;14(4):269-275.
33. Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstet Gynaecol 1990;97(7):595-602.
34. Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 1995;5(6):695-701.
35. Müller-Schimpfle M, Ohmenhaüser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997;203(1):145-149.
36. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997;203(1):137-144.
37. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981;104(1):23-34.
38. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10(6):382-393.
39. Going JJ, Anderson TJ, Battersby S, MacIntyre CC. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1988;130(1):193-204.
40. Feuerhake F, Sigg W, Höfter EA, Unterberger P, Welsch U. Cell proliferation, apoptosis, and expression of Bcl-2 and Bax in non-lactating human breast epithelium in relation to the menstrual cycle and reproductive history. Breast Cancer Res Treat 2003;77(1):37-48.
41. Potten CS, Watson RJ, Williams GT, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988;58(2):163-170.
42. Simpson HW, Cornélissen G, Katinas G, Halberg F. Meta-analysis of sequential luteal-cycle-associated changes in human breast tissue. Breast Cancer Res Treat 2000;63(2):171-173.
43. Morrow M. The evaluation of common breast problems. Am Fam Physician 2000;61(8):2371-2378, 2385.
44. Silvestrini R, Luisi A, Daidone MG, Di Mauro MG. Effect of menstrual phase on cell proliferative rate of breast cancer. Breast Cancer Res Treat 1998;48(1):93-94.
45. Wegienka G, Baird DD. A comparison of recalled date of last menstrual period with prospectively recorded dates. J Womens Health (Larchmt) 2005;14(3):248-252.
46. Weinberg CR, Umbach DM, Greenland S. When will nondifferential misclassification of an exposure preserve the direction of a trend? Am J Epidemiol 1994;140(6):565-571.